Meghan Norris Bradley

Title: Innovations and Contributions of Meghan Norris Bradley

Introduction

Meghan Norris Bradley is a prominent inventor based in Mebane, North Carolina. She has made significant contributions to the field of enzymology and proteomics, holding a total of five patents. Her work focuses on developing methods and systems that enhance diagnostic capabilities in medical science.

Latest Patents

Among her latest patents is a method for determining ADAMTS13 enzyme activity. This invention provides valuable techniques for analyzing the activity of the enzyme disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) in various samples. This method is particularly useful for diagnosing thrombotic thrombocytopenic purpura in patients. Another notable patent involves methods and systems for LC-MS/MS proteomic genotyping. This invention utilizes liquid chromatography/tandem mass spectrometry for the proteomic analysis of genotypes, with certain embodiments using dried bodily fluids for analysis.

Career Highlights

Meghan currently works at Laboratory Corporation of America Holdings, where she applies her expertise in enzymology and proteomics. Her innovative approaches have contributed to advancements in diagnostic methods, enhancing the accuracy and efficiency of medical testing.

Collaborations

Meghan collaborates with notable colleagues, including Russell Philip Grant and Christopher Michael Shuford. Their combined efforts in research and development have led to significant advancements in their respective fields.

Conclusion

Meghan Norris Bradley's contributions to science through her patents and collaborative efforts highlight her role as an influential inventor. Her work continues to impact the medical field positively, paving the way for improved diagnostic techniques.